Melroy A. D’Souza

Hepatopancreatoduodenectomy –a controversial treatment for bile duct and gallbladder cancer from a European perspective

Melroy A. D’Souza, Valentinus Valdimarsson, Tommaso Campagnaro et al. · HPB · 2019 · 51 citations · Full text

Surgical Oncology, Hepatology, Biliary Tract +11

Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification

Carlos Fernández Moro, Alejandro Fernandez-Woodbridge, Melroy A. D’Souza et al. · PLoS ONE · 2016 · 44 citations · Full text

The Gray Zone Between Postpancreaticoduodenectomy Collections and Pancreatic Fistula

Savio George Barreto, Melroy A. D’Souza, Parul J. Shukla et al. · Pancreas · 2008 · 29 citations

Mechanisms for skeletal muscle insulin resistance in patients with pancreatic ductal adenocarcinoma

Thorhallur Agustsson, Melroy A. D’Souza, Greg Nowak et al. · Nutrition · 2010 · 27 citations

Insulin Resistance, Pancreatic Cancer, Physiology +4

Borderline resectable pancreatic tumors: Is there a need for further refinement of this stage?

Shailesh V. Shrikhande, Supreeta Arya, Savio George Barreto et al. · Hepatobiliary & pancreatic diseases international · 2011 · 25 citations

Pancoast Syndrome, Surgical Oncology, Pancreatic Cancer +9